The Department of Health and Human Services (HHS) will award roughly $590 million to Moderna to accelerate the development of mRNA-based pandemic influenza vaccines, including vaccines for avian flu ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Earlier this month, Moderna announced business updates and progress across its pipeline. Moderna says it enters 2025 with a ...

Key Takeaways Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be ...

The funding, which follows the $176 million the government awarded Moderna in June 2024, aims to get mRNA vaccines ready ...

The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to ...

The Department of Health and Human Services has granted millions of dollars to Moderna to speed up bird flu vaccine development.

The government wants Moderna to push forward with various bird flu vaccines as well as mRNA shots for other influenza strains ...

The misery of the common stomach flu may be coming to an end. Pharmaceutical company Moderna has launched a large-scale Phase ...

The U.S. government has awarded Moderna $590 million to advance the development of its bird flu vaccine, as the country doubles down on efforts to tackle increasing infections in humans.

Merck shares trade at a significant discount to peers. The company faces challenges, but there are reasons to be bullish.